ViewRay Inc. (VRAY)

9.15
NASDAQ : Health Technology
Prev Close 9.35
Day Low/High 9.13 / 9.36
52 Wk Low/High 4.86 / 13.21
Avg Volume 869.80K
Exchange NASDAQ
Shares Outstanding 96.95M
Market Cap 906.51M
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)
ViewRay Announces Appointment Of Dr. Gail Wilensky To Its Board Of Directors

ViewRay Announces Appointment Of Dr. Gail Wilensky To Its Board Of Directors

CLEVELAND, July 16, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced the appointment of Dr.

Noteworthy Thursday Option Activity: VRAY, TITN, MRK

Noteworthy Thursday Option Activity: VRAY, TITN, MRK

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in ViewRay Inc , where a total volume of 6,309 contracts has been traded thus far today, a contract volume which is representative of approximately 630,900 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 78.6% of VRAY's average daily trading volume over the past month, of 802,465 shares.

Leading Medical Physics Meeting To Feature More Than 40 Presentations On ViewRay's MRIdian MRI-Guided Radiotherapy

Leading Medical Physics Meeting To Feature More Than 40 Presentations On ViewRay's MRIdian MRI-Guided Radiotherapy

Presentations Highlight MRIdian Clinical Experience with Real-Time On-Table Adaptive Radiotherapy at a Growing Number of Institutions Worldwide

First Week Of July 19th Options Trading For ViewRay (VRAY)

First Week Of July 19th Options Trading For ViewRay (VRAY)

Investors in ViewRay Inc saw new options become available this week, for the July 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VRAY options chain for the new July 19th contracts and identified one put and one call contract of particular interest.

World's First MRIdian Center Treats 1,000th Patient With MRI-Guided Radiation Therapy

World's First MRIdian Center Treats 1,000th Patient With MRI-Guided Radiation Therapy

Extensive Clinical Experience at Siteman Cancer Center Helps Further Adoption and Clinical Practice of MR-guided and On-Table Adaptive Radiation Therapy

ViewRay® To Present At The Jefferies 2019 Global Healthcare Conference

ViewRay® To Present At The Jefferies 2019 Global Healthcare Conference

CLEVELAND, May 16, 2019 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the Company will participate in the Jefferies 2019 Global Healthcare Conference in New York, New York.

VRAY Crosses Above Key Moving Average Level

VRAY Crosses Above Key Moving Average Level

In trading on Wednesday, shares of ViewRay Inc crossed above their 200 day moving average of $8.22, changing hands as high as $8.44 per share. ViewRay Inc shares are currently trading up about 4.9% on the day.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: APO, CKH, CLCT, EARN, ERII, HCI, INN, KEN, LH, PBF, PPDF, PXLW, SHAK, TS Downgrades: D, EPAY, GSIT, HPP, REGI, RIVE, TDC, TYPE, VIRT, VRAY Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

ViewRay Reports First Quarter 2019 Results

ViewRay Reports First Quarter 2019 Results

CLEVELAND, May 2, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the first quarter ended March 31, 2019.

ViewRay Enters Oversold Territory (VRAY)

ViewRay Enters Oversold Territory (VRAY)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

ViewRay's MRIdian To Be Featured At Leading European Radiation Oncology Meeting

ViewRay's MRIdian To Be Featured At Leading European Radiation Oncology Meeting

26 Clinical Presentations and Posters Highlight Benefits of MRI-Guided Radiation Therapy Across Applications and Growing Use of Adaptive Therapy

ViewRay Partners With Leading Canadian Distributor To Bring MRI-guided Radiation Therapy To Canada

ViewRay Partners With Leading Canadian Distributor To Bring MRI-guided Radiation Therapy To Canada

Minogue Medical to Serve as Exclusive Canadian Distributor for ViewRay's MRIdian System

ViewRay Announces Conference Call And Webcast Of First Quarter 2019 Financial Results To Be Held After Market On May 2, 2019

ViewRay Announces Conference Call And Webcast Of First Quarter 2019 Financial Results To Be Held After Market On May 2, 2019

CLEVELAND, April 11, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2019 financial results.

ViewRay Announces Publication Of Retrospective Study On MR-guided Radiation Treatment For Locally Advanced Pancreatic Cancer

ViewRay Announces Publication Of Retrospective Study On MR-guided Radiation Treatment For Locally Advanced Pancreatic Cancer

High-Dose Radiation Therapy Enabled by MRIdian's Daily On-table Adaptation and Gating Beam Control Results in Excellent Retrospective Local Tumor Control, Low Toxicity, and Outstanding Overall Survival versus Non-adaptive Treatment

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: COHR, DDD, GIII, QADA, QADB, QIWI, VRAY Downgrades: None Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

ViewRay (VRAY) Shares Cross Below 200 DMA

ViewRay (VRAY) Shares Cross Below 200 DMA

In trading on Friday, shares of ViewRay Inc crossed below their 200 day moving average of $8.25, changing hands as low as $7.80 per share. ViewRay Inc shares are currently trading off about 3.5% on the day.

ViewRay Reports Fourth Quarter And Full Year 2018 Results

ViewRay Reports Fourth Quarter And Full Year 2018 Results

CLEVELAND, March 14, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the fourth quarter and full year ended December 31, 2018.

ViewRay Announces FDA 510(k) Clearance For Advancements In MRI And Functional Imaging Technologies For MRIdian MRI-Guided Radiation Therapy System

ViewRay Announces FDA 510(k) Clearance For Advancements In MRI And Functional Imaging Technologies For MRIdian MRI-Guided Radiation Therapy System

Proprietary Technology from ViewRay Enables Imaging and Treatment Enhancements

World's First MRIdian Center Celebrates Five Years Of MRI-Guided Radiation Treatments

World's First MRIdian Center Celebrates Five Years Of MRI-Guided Radiation Treatments

Siteman Cancer Center Advances Precision Cancer Care through Presentations, Peer-Reviewed Publications and Pioneering Clinical Experience on its MRIdian Systems

Moderna, MyoKardia Are Among Cutting-Edge Biotech Stocks for 2019

Moderna, MyoKardia Are Among Cutting-Edge Biotech Stocks for 2019

Moderna only went public in December, and is already creating a buzz.

First Week Of February 15th Options Trading For ViewRay (VRAY)

First Week Of February 15th Options Trading For ViewRay (VRAY)

Investors in ViewRay Inc saw new options become available this week, for the February 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VRAY options chain for the new February 15th contracts and identified the following call contract of particular interest.

Relative Strength Alert For ViewRay

Relative Strength Alert For ViewRay

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Will Insiders Be Tempted To Buy More VRAY At The New 52-Week Low?

Will Insiders Be Tempted To Buy More VRAY At The New 52-Week Low?

In trading on Tuesday, shares of ViewRay Inc touched a new 52-week low of $5.80/share. That's a $7.41 share price drop, or -56.09% decline from the 52-week high of $13.21 set back on 07/25/2018.

ViewRay Is Now Oversold (VRAY)

ViewRay Is Now Oversold (VRAY)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

VRAY Crosses Above Key Moving Average Level

VRAY Crosses Above Key Moving Average Level

In trading on Wednesday, shares of ViewRay Inc crossed above their 200 day moving average of $8.47, changing hands as high as $8.78 per share. ViewRay Inc shares are currently trading up about 5.9% on the day.

First Week Of VRAY January 2021 Options Trading

First Week Of VRAY January 2021 Options Trading

Investors in ViewRay Inc saw new options begin trading this week, for the January 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 849 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Oversold Conditions For ViewRay (VRAY)

Oversold Conditions For ViewRay (VRAY)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

VRAY Crosses Above Average Analyst Target

VRAY Crosses Above Average Analyst Target

In recent trading, shares of ViewRay Inc have crossed above the average analyst 12-month target price of $12.42, changing hands for $12.44/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

TheStreet Quant Rating: D (Sell)